Link to Bee Editorial Repaired
Posted on June 24th, 2009 | by Stem Cell News |The “time is ripe” item below (June 21) had a bad link to The Bee editorial. The link has been fixed, and you can find the editorial here.
-
Blog Lounge
Recent Post
- 2-Arylthiazolidine-4-carboxylic acid amides (ATCAA) target dual pathways in cancer cells: 5′-AMP-activated protein kinase (AMPK)/mTOR and PI3K/Akt/mTOR pathways.
- Effect of rapamycin, an mTOR inhibitor, on radiation sensitivity of lung cancer cells having different p53 gene status.
- Phospholipase D-mTOR requirement for the Warburg effect in human cancer cells.
- Steady-State Kinetic and Inhibition Studies of the mTOR Kinase Domain and mTOR Complexes.
- mTOR Signaling is Involved in Indomethacin and Nimesulide Suppression of Colorectal Cancer Cell Growth via a COX-2 Independent Pathway.
- mTOR Inhibition Abrogates Insulin-Mediated Mammary Tumor Progression in Type 2 Diabetes.
- Tel2 structure and function in the Hsp90-dependent maturation of mTOR and ATR complexes.
- Autosomal dominant polycystic kidney disease and mTOR inhibitors: the narrow road between hope and disappointment.
- PKI-179: An orally efficacious dual phosphatidylinositol-3-kinase (PI3K)/mammalian target of rapamycin (mTOR) inhibitor.
- Nutrient withdrawal rescues growth factor-deprived cells from mTOR-dependent damage.